Study S000640

GLP-1 Receptor Agonists Prevent Alzheimer's Disease Onset, Not Progression: Resolving the Real-World-Randomised Trial Paradox Across Five Continents

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07677865
Acronym: GLP1-AD-TTE
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 213891
Start: 2007-01-01
Primary completion: 2024-12-31
Lead sponsor: West China Hospital
Conditions: Alzheimer Disease; Diabetes Mellitus Type 2; Obesity & Overweight
Interventions: DRUG:GLP-1 Receptor Agonists; DRUG:DPP-4 Inhibitors
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Incidence of Alzheimer's Disease [Up to 10 years (from index date of medication initiation to date of first AD diagnosis, death, or end of follow-up, whichever occurs first).]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.